Losartan potassium
USP/1370462 - United States Pharmacopeia (USP) Reference Standard
Synonym: 2-
CAS Number: 124750-99-8
Empirical Formula (Hill Notation): C22H22ClKN6O
Molecular Weight: 461.00
MDL Number: MFCD02092704
Linear Formula: C22H22ClKN6O
Product Type: Chemical
| API family | losartan |
| application(s) | pharmaceutical (small molecule) |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C22H22ClN6O.K/c1-2-3-8 |
| InChI key | OXCMYAYHXIHQOA-UHFFFAOYSA |
| manufacturer/tradename | USP |
| SMILES string | CCCCc1nc(Cl)c(CO)n1Cc2ccc |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Losartan potassium USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as: • Losartan Potassium and Hydrochlorothiazide Tablets • Losartan Potassium Tablets |
| Biochem/physiol Actions: | Losartan potassium is an orally available, potent, and selective competitive angiotensin II receptor type 1 (AT1) antagonist. Losartan potassium is used for treatment of hypertension. |
| Biochem/physiol Actions: | orally available, potent, and selective competitive angiotensin II receptor type 1 (AT1) antagonist |
| General description: | Losartan potassium is a new drug used for hypertension. It is nonpeptide angiotensin II (AII) receptor antagonist. |
| General description: | Losartan potassium is nonpeptide angiotensin II (AII) receptor antagonist and is orally active. It belongs to a new class of drugs introduced for clinical trials to treat hypertension. |
| Other Notes: | Sales restrictions may apply. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 41116107 |
